Annual Non Current Assets
$20.67 M
+$2.25 M+12.24%
December 31, 2024
Summary
- As of March 10, 2025, VRNA annual long term assets is $20.67 million, with the most recent change of +$2.25 million (+12.24%) on December 31, 2024.
- During the last 3 years, VRNA annual non current assets has risen by +$4.15 million (+25.09%).
- VRNA annual non current assets is now at all-time high.
Performance
VRNA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$20.67 M
+$3.10 M+17.68%
December 31, 2024
Summary
- As of March 10, 2025, VRNA quarterly long term assets is $20.67 million, with the most recent change of +$3.10 million (+17.68%) on December 31, 2024.
- Over the past year, VRNA quarterly non current assets has increased by +$2.25 million (+12.24%).
- VRNA quarterly non current assets is now -38.03% below its all-time high of $33.35 million, reached on September 30, 2020.
Performance
VRNA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
VRNA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.2% | +12.2% |
| 3 y3 years | +25.1% | +12.2% |
| 5 y5 years | +967.7% | +12.2% |
VRNA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.5% | at high | +29.6% |
| 5 y | 5-year | at high | +1114.5% | -38.0% | +1234.4% |
| alltime | all time | at high | -100.0% | -38.0% | -100.0% |
Verona Pharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $453.57 M(+56.6%) | $20.67 M(+17.7%) |
| Sep 2024 | - | $17.57 M(-1.5%) |
| Jun 2024 | - | $17.83 M(-1.3%) |
| Mar 2024 | - | $18.07 M(-1.9%) |
| Dec 2023 | $289.71 M(+19.2%) | $18.42 M(+15.5%) |
| Sep 2023 | - | $15.94 M(-1.0%) |
| Jun 2023 | - | $16.10 M(-1.0%) |
| Mar 2023 | - | $16.25 M(-1.3%) |
| Dec 2022 | $243.00 M(+42.9%) | $16.47 M(+0.3%) |
| Sep 2022 | - | $16.42 M(+1.2%) |
| Jun 2022 | - | $16.22 M(-0.8%) |
| Mar 2022 | - | $16.36 M(-1.0%) |
| Dec 2021 | $170.06 M(-16.0%) | $16.52 M(-3.2%) |
| Sep 2021 | - | $17.07 M(+669.2%) |
| Jun 2021 | - | $2.22 M(+43.3%) |
| Mar 2021 | - | $1.55 M(-9.0%) |
| Dec 2020 | $202.50 M(+272.9%) | $1.70 M(-94.9%) |
| Sep 2020 | - | $33.35 M(+0.3%) |
| Jun 2020 | - | $33.24 M(+501.8%) |
| Mar 2020 | - | $5.52 M(+185.3%) |
| Dec 2019 | $54.30 M(-40.3%) | $1.94 M(-58.8%) |
| Sep 2019 | - | $4.70 M(+31.2%) |
| Jun 2019 | - | $3.58 M(-4.7%) |
| Mar 2019 | - | $3.76 M(-3.8%) |
| Dec 2018 | $90.94 M | $3.91 M(+15.8%) |
| Sep 2018 | - | $3.37 M(+1.1%) |
| Jun 2018 | - | $3.34 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $3.57 M(+8.8%) |
| Dec 2017 | $117.68 M(+117.7%) | $3.28 M(-0.4%) |
| Sep 2017 | - | $3.29 M(+4.8%) |
| Jun 2017 | - | $3.14 M(+9.2%) |
| Dec 2016 | $54.05 M(+554.8%) | $2.88 M(+14.5%) |
| Jun 2016 | - | $2.51 M(-25.2%) |
| Dec 2015 | $8.26 M(-52.9%) | $3.36 M(+20.5%) |
| Jun 2015 | - | $2.79 M(-4.3%) |
| Dec 2014 | $17.52 M(+1145.1%) | $2.91 M(-7.1%) |
| Jun 2014 | - | $3.13 M(+11.5%) |
| Dec 2013 | $1.41 M(-25.5%) | $2.81 M(+11.1%) |
| Jun 2013 | - | $2.53 M(-4.3%) |
| Dec 2012 | $1.89 M(-53.5%) | $2.64 M(+5.9%) |
| Jun 2012 | - | $2.49 M(+1.0%) |
| Dec 2011 | $4.06 M(+27.1%) | $2.47 M(-2.4%) |
| Jun 2011 | - | $2.53 M(+3.4%) |
| Dec 2010 | $3.20 M(-38.4%) | $2.45 M(+3.2%) |
| Jun 2010 | - | $2.37 M(-6.0%) |
| Dec 2009 | $5.19 M(+40.5%) | $2.52 M(-1.4%) |
| Jun 2009 | - | $2.55 M(+12.2%) |
| Dec 2008 | $3.69 M(+24.8%) | $2.28 M(-26.6%) |
| Jun 2008 | - | $3.10 M(+0.8%) |
| Dec 2007 | $2.96 M(-37.5%) | $3.08 M(-1.1%) |
| Jun 2007 | - | $3.11 M(+2.6%) |
| Dec 2006 | $4.73 M(+177.6%) | $3.03 M(>+9900.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Dec 2005 | $1.71 M | $0.00(0.0%) |
| Jun 2005 | - | $0.00 |
FAQ
- What is Verona Pharma annual long term assets?
- What is the all time high annual non current assets for Verona Pharma?
- What is Verona Pharma annual non current assets year-on-year change?
- What is Verona Pharma quarterly long term assets?
- What is the all time high quarterly non current assets for Verona Pharma?
- What is Verona Pharma quarterly non current assets year-on-year change?
What is Verona Pharma annual long term assets?
The current annual non current assets of VRNA is $20.67 M
What is the all time high annual non current assets for Verona Pharma?
Verona Pharma all-time high annual long term assets is $20.67 M
What is Verona Pharma annual non current assets year-on-year change?
Over the past year, VRNA annual long term assets has changed by +$2.25 M (+12.24%)
What is Verona Pharma quarterly long term assets?
The current quarterly non current assets of VRNA is $20.67 M
What is the all time high quarterly non current assets for Verona Pharma?
Verona Pharma all-time high quarterly long term assets is $33.35 M
What is Verona Pharma quarterly non current assets year-on-year change?
Over the past year, VRNA quarterly long term assets has changed by +$2.25 M (+12.24%)